Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,966Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-176.7EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %6.3PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with JNK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNKKen Fisher 2016-09-30 Add0.04%$35.36 - $36.73
($36.26)
$ 36.01-1%Add 142.18%1,042,048
JNKKen Fisher 2016-06-30 Reduce$33.87 - $35.69
($34.94)
$ 36.013%Reduce -0.73%430,284
JNKKen Fisher 2016-03-31 Reduce$31.49 - $34.54
($33.18)
$ 36.019%Reduce -0.66%433,462
JNKKen Fisher 2015-12-31 Add0.01%$33.42 - $36.6
($35.35)
$ 36.012%Add 24.20%436,338
JNKKen Fisher 2015-09-30 Add0.03%$35.56 - $38.4
($37.29)
$ 36.01-3%Add 1096.69%351,325
JNKKen Fisher 2015-06-30 Reduce$38.31 - $39.61
($39.17)
$ 36.01-8%Reduce -9.30%29,358
JNKKen Fisher 2015-03-31 Reduce$38.23 - $39.78
($39.1)
$ 36.01-8%Reduce -0.92%32,369
JNKKen Fisher 2014-06-30 Add$41.05 - $41.8
($41.39)
$ 36.01-13%Add 25.47%34,854
JNKHOTCHKIS & WILEY 2014-03-31 Sold Out -0.049%$35.88 - $36.96
($36.43)
$ 36.01-1%Sold Out0
JNKHOTCHKIS & WILEY 2013-12-31 Buy 0.05%$39.77 - $40.75
($40.44)
$ 36.01-11%New holding282,900
JNKKen Fisher 2013-06-30 Add$38.7 - $41.94
($40.87)
$ 36.01-12%Add 33.93%25,149
JNKKen Fisher 2013-03-31 Add$40.43 - $41.37
($40.95)
$ 36.01-12%Add 84.70%18,778
JNKKen Fisher 2012-09-30 Add$39.17 - $40.77
($39.86)
$ 36.01-10%Add 61.31%13,534
JNKKen Fisher 2012-06-30 Buy $37.63 - $39.66
($38.92)
$ 36.01-7%New holding8,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Brown, ArthurDirector, Senior Officer 2016-11-08Buy25,000$0.2812760.71view
BACH, WENDYSenior Officer 2016-11-08Sell3,549$48.06-25.07view
BACH, WENDYSenior Officer 2016-11-08Buy4,619$48.08-25.1view
BACH, WENDYSenior Officer 2016-11-08Sell1,070$48.06-25.07view
Miller, James MichaelSenior Officer 2016-11-08Buy5,000$4.3737.44view
Omni-Lite Industries Canada InIssuer 2016-11-08Buy2,300$1.652082.42view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-11-08Buy13,000$0.1327600view
Glazier, Patrick L.Director 2016-11-08Buy100,000$0.1425621.43view
Sutton, Brayden RobertDirector 2016-11-08Buy5,000$0.2812760.71view
Reilly, Robert BruceSenior Officer 2016-11-08Sell155,000$0.0659916.67view

Quarterly/Annual Reports about JNK:

    News about JNK:

    Articles On GuruFocus.com
    Low-Priced Retail Stocks Gurus Shopped for Ahead of Holiday Season Dec 02 2016 
    Barrick Repurchases $595 Million of Corporate Loan Dec 02 2016 
    23 Questions With Bakul Lalla Dec 02 2016 
    Qualcomm: Balance Sheet, Dividend Yield Make It Attractive Dec 02 2016 
    Apple: A Dividend Achiever in the Making Dec 02 2016 
    Neiman Marcus Debenture Bonds Yielding 8% Dec 02 2016 
    Competitor Performance Is Eating Nike’s Lunch Dec 02 2016 
    Smith & Wesson Reports Strong Quarter, but Stock Suffers Post Election Dec 02 2016 
    6 Things That May Surprise You About Building Wealth Dec 02 2016 
    Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals Dec 02 2016 

    More From Other Websites
    Bond ETFs May Offer Liquidity, But It's Not Free Dec 02 2016
    Rate Hike and Appreciated Dollar May not help Gold Nov 30 2016
    Bull Market: Expected for Gold but Not for Bonds Nov 30 2016
    3 ETFs For A Trump Presidency Nov 28 2016
    [video]How to Trade Rising Bond Yields, Falling Gold, Stabilizing Utilities Nov 28 2016
    What's Next For Bond Yields? Nov 26 2016
    Charts Show Bonds, Gold, Utilities Took a Huge Hit Nov 21 2016
    Facebook, Home Depot, Disney: Doug Kass' Views Nov 21 2016
    At the Cato Institute’s 34th Annual Monetary Conference (Panel 3) Nov 17 2016
    At the Cato Institute’s 34th Annual Monetary Conference (Lunch) Nov 17 2016
    At the Cato Institute’s 34th Annual Monetary Conference (Panel 2) Nov 17 2016
    At the Cato Institute’s 34th Annual Monetary Conference (Panel 1) Nov 17 2016
    Bernstein Shows the Opportunity Cost of Not Investing in Equities Nov 16 2016
    How to Play the Gold Slump, Bond Yield Jump Nov 14 2016
    Corporate bond ETFs suffer huge outflows as investors get set for Trump Nov 14 2016
    Weird Begets Weird Nov 09 2016
    The Sun Will Rise Tomorrow, DV Nov 08 2016
    Clinton victory on Election Day could trigger a rally in this risky asset Nov 07 2016
    How to Trade the Bounce on Gold, Utilities as Stocks and Yields Fall Nov 07 2016
    U.S. junk bond ETFs snap 7-day losing streak Nov 03 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)